Stock

Bath & Body Works

BBWI

Specialty Retail · Consumer Cyclical

Also trades as: 0JSC.L GBP 0.21 (-1.14%)

Price

$20.95

-0.65 (-3.01%)

Market Cap

$4.22B

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Oct 24, 2026 · filings through Aug 1, 2026

§How the score breaks down

Quality

Mixed

14/30

Growth

Mixed

5/20

Cash Flow

Exceptional

9/10

Stability

Mixed

3/10

Valuation

Good

6/10

Ownership

Weak

2/15

Dividends

Good

3/5

42 of 100 counted points = Winston Score 42.

Track this stock — start free trial

Share count falling — buybacks

−22.5% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 273.0M (2022) → 211.6M (2026)

§Winston Score History

The full picture

Bath & Body Works sells personal care and home fragrance products. Its most well-known items include scented candles, soaps, lotions, and body sprays sold under its own brand name. The company sells directly to everyday consumers, mostly women, through its own retail stores and website across the United States and Canada.

The company makes money primarily by selling products in its roughly 1,800 company-owned stores, plus a growing online channel. Nearly all revenue comes from North America, making it heavily dependent on the U.S. consumer. Its moat comes from strong brand loyalty, exclusive proprietary scents, and a store experience that drives frequent repeat visits — the company regularly launches limited-edition collections to keep customers coming back. The key risk is that Bath & Body Works sells discretionary products, meaning shoppers can easily cut back during tough economic times, which puts pressure on sales when consumer confidence drops.

Politician Trades

1 trades / 12mo

0 Congressional buys and 1 sell on BBWI in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

45.7%

Healthy — 45.7% gross margin

Profit after running costs

Operating Margin

14.3%

Healthy — 14.3% operating margin

Return on the money invested

ROCE

7.8%

Weak — 7.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-2.2%

Shrinking sales (-2.2% YoY)

Profit growth

EPS YoY

+10.9%

Earnings growing (+10.9% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

163%

Turns 163% of profit into real cash

Spare cash per sale

FCF Margin

14.3%

Converts sales into free cash efficiently (14.3%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

—

Data not available

Covers its interest

Interest Cover

4.49x

Adequate interest coverage (4.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

5.6x

Attractive valuation — P/E 5.6

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year

P/E vs Forward

-2.0

SLOWING

Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

4.03%

Healthy income — 4.03% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record

Dividend Growth

+0.0%

Dividend flat

Payout Ratio

21%

no trend

Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial